Search research articles
Contact Us
Filters
Showing results (311-320 of 368) with videos related to
Page
of 37
Sort By:
Journal of Clinical Medicine
|
March 29, 2023
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, et al.
Journal of Clinical Medicine
|
July 29, 2025
Integrating New Technologies in Lipidology: A Comprehensive Review
Carlos Escobar-Cervantes, Jesús Saldaña-García, Ana Torremocha-López, et al.
Expert Review of Cardiovascular Therapy
|
June 16, 2025
Artificial intelligence: a promising tool for the clinical cardiologist
Carlos Escobar, Lorenzo Facila, Rafael Vidal-Pérez, et al.
Current Medical Research and Opinion
|
March 10, 2023
Identifying the patient with heart failure to be treated with vericiguat
Carlos Escobar Cervantes, Alberto Esteban Fernández, Alejandro Recio Mayoral, et al.
Expert Opinion on Pharmacotherapy
|
March 24, 2023
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization
Alberto Esteban Fernández, Alejandro Recio Mayoral, Alvaro González Franco, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 11, 2023
Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019
Juan A Divison-Garrote, Julio A Carbayo-Herencia, Marta Simarro-Rueda, et al.
Endocrinologia, Diabetes Y Nutricion
|
November 19, 2022
Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]
Juan Pedro-Botet, Vivencio Barrios, Víctor Sánchez-Margalet, et al.
Frontiers in Cardiovascular Medicine
|
November 24, 2025
Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studies
Carlos Escobar, Pedro Caravaca-Pérez, Jose Maria Fernandez Rodriguez, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
November 5, 2004
Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers
Antonio H Madrid, Irene Marín Marín, Carlos Escobar Cervantes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 28, 2020
SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
Carlos Escobar, Vivencio Barrios, Juan Cosín, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 368) with videos related to
Sort By:
Page
of 37
Journal of Clinical Medicine
|
March 29, 2023
Burden of Illness beyond Mortality and Heart Failure Hospitalizations in Patients Newly Diagnosed with Heart Failure in Spain According to Ejection Fraction
Carlos Escobar, Beatriz Palacios, Victoria Gonzalez, et al.
Journal of Clinical Medicine
|
July 29, 2025
Integrating New Technologies in Lipidology: A Comprehensive Review
Carlos Escobar-Cervantes, Jesús Saldaña-García, Ana Torremocha-López, et al.
Expert Review of Cardiovascular Therapy
|
June 16, 2025
Artificial intelligence: a promising tool for the clinical cardiologist
Carlos Escobar, Lorenzo Facila, Rafael Vidal-Pérez, et al.
Current Medical Research and Opinion
|
March 10, 2023
Identifying the patient with heart failure to be treated with vericiguat
Carlos Escobar Cervantes, Alberto Esteban Fernández, Alejandro Recio Mayoral, et al.
Expert Opinion on Pharmacotherapy
|
March 24, 2023
Optimizing the management of patients with worsening heart failure: beyond heart failure hospitalization
Alberto Esteban Fernández, Alejandro Recio Mayoral, Alvaro González Franco, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 11, 2023
Prognosis of Systolic Pressure 130 to 139 According to Risk. A Prospective Cohort Study Between 1992 and 2019
Juan A Divison-Garrote, Julio A Carbayo-Herencia, Marta Simarro-Rueda, et al.
Endocrinologia, Diabetes Y Nutricion
|
November 19, 2022
Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]
Juan Pedro-Botet, Vivencio Barrios, Víctor Sánchez-Margalet, et al.
Frontiers in Cardiovascular Medicine
|
November 24, 2025
Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studies
Carlos Escobar, Pedro Caravaca-Pérez, Jose Maria Fernandez Rodriguez, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
November 5, 2004
Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers
Antonio H Madrid, Irene Marín Marín, Carlos Escobar Cervantes, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 28, 2020
SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
Carlos Escobar, Vivencio Barrios, Juan Cosín, et al.
Page
of 37